The management of asthmatic smokers

Juan Carlos Ivancevich Monday, 27 June 2016 18:28
José Miguel Chatkin Email author and Cynthia Rocha Dullius

 

Abstract

Asthma is still a major public health problem in most countries; new strategies to better control this disease are necessary. Such strategies must include predisposing factors. One of these factors is smoking and a significant fraction of asthmatics are smokers. However, clinical trials studying new drugs or newer therapeutic regimens for asthma generally exclude smokers. Therefore, there is a lack of specific information about the treatment of asthma in smokers. The asthmatic smoker is a special phenotype with important therapeutic and prognostic clinical implications. Any form of tobacco use, especially cigarette smoking, plays an important role in this disease. Asthmatic smokers are prone to several negative outcomes. Smoking cessation results in an improvement of symptoms and pulmonary functioning. Counselling and first-line medications for smoking cessation (nicotine replacement therapy, bupropion and varenicline) significantly increase quitting rates. The role of electronic cigarettes in this group of patients has only begun to be studied. The treatment of asthmatics that smoke has characteristics that need must be well understood by clinicians, especially the poor response to corticosteroids. This condition is not universal and physicians should always consider its inclusion in the treatment of these patients. The association of inhaled corticosteroids (ICS) plus a long-acting beta2 adrenegic (LABA) by smoking asthmatics results in more pronounced improvement in several asthma outcomes compared with the use of corticosteroid alone. Inhaled corticosteroids in extra-fine particles associated with LABA may be a new perspective of treatment. Also the use of leukotriene antagonists may become another therapeutic alternative. The purpose of this narrative review is to discuss the challenges faced by clinicians to control asthma in smokers and to present methods of coping with smoking treatment and avoiding relapses.

Download PDF

 

Asthma Research and Practice celebrates its first anniversary

Juan Carlos Ivancevich Monday, 06 June 2016 17:54

As open access journal Asthma Research and Practice celebrates its first anniversary, we are pleased to bring you a selection of recently published articles. We hope you find the articles of interest and invite you to submit your next manuscript to the journal.

We also encourage you to read our blog post for World Asthma Day as well as more asthma-related posts.

Featured Articles

REVIEW

Asthma and obesity: mechanisms and clinical implications

Cynthia Wilson Baffi, Daniel Efrain Winnica and Fernando Holguin

Abstract   |  Full text   |  PDF

RESEARCH

Vitamin D supplementation decreases Aspergillus fumigatus specific Th2 responses in CF patients with aspergillus sensitization: a phase one open-label study

Nguyen et al.

Abstract   |  Full text   |  PDF

RESEARCH

A qualitative evaluation of the implementation of guidelines and a support tool for asthma management in primary care

Watkins et al.

Abstract   |  Full text   |  PDF

About the Journal

Asthma Research and Practice is the official publication of Interasma and publishes cutting edge basic, clinical and translational research in addition to hot topic reviews and debate articles relevant to asthma and related disorders (such as rhinitis, COPD overlapping syndrome, sinusitis). The journal has a specialized section which focusses on pediatric asthma research.

Asthma Research and Practice aims to serve as an international platform for the dissemination of research of interest to pulmonologists, allergologists, primary care physicians and family doctors, ENTs and other health care providers interested in asthma, its mechanisms and comorbidities.

Reasons to Publish with Us

  • The official journal of Interasma
  • Dedicated section on pediatric asthma
  • Translating research from bench to bedside

 

 

Asthma Research and Practice: Potential of molecular based diagnostics and its impact on allergen immunotherapy

Juan Carlos Ivancevich Friday, 03 June 2016 12:43

 

The following new article has just been published in Asthma Research and Practice

Review   

Potential of molecular based diagnostics and its impact on allergen immunotherapy

Melioli G, Savi E, Crivellaro M, Passalacqua G

Asthma Research and Practice 2016, 2 :9 (2 June 2016)

Abstract

Molecular based in vitro technologies greatly changed the diagnostic approaches in allergy. At present, sensitization profiles can be dissected according to IgE subsets, which are specific for genuine or cross-reacting components and potentially dangerous or virtually harmless components. The identification of IgE in components with specific characteristics has a direct impact on the accuracy of the diagnosis (indeed, it is possible at present to not only identify the allergen derived from a given allergen source but also the family of molecules to which the patient is sensitized), on the prognosis of the patient’s allergy, and on the prevention activities to be implemented. More interestingly, during the last few years, and thanks to the tools of molecular diagnostics, the indications for Allergen Immunotherapy (AIT) have also be modified, and novel strategies for the selection of the allergens to be administered have been better defined. Indeed, protocols indicating how Molecular Based Diagnosis (MBD) can be used to identify the best AIT approach have been recently published. In this review, the rationale for the use of MBD tools is discussed, and the recent strategies for the choice of allergens to be used in AIT are reported.

 Full Text | PDF

May 2nd is Now "Bronchial Thermoplasty Awareness Day" in Pennsylvania

Juan Carlos Ivancevich Friday, 13 May 2016 22:21

 Asthma is a disease that causes the airways of the lungs to swell and narrow, leading to wheeze, shortness of breath, chest tightness, and cough. Asthma is the most common chronic lung disease, affecting up to 10% of adults and 30% of children. Bronchial Thermoplasty (BT) is one of the treatment options for severe asthma - see below:




Asthma Treatment Options in 6 Steps (click to enlarge the image).

May 2nd is Now "Bronchial Thermoplasty Awareness Day" in Pennsylvania. From the manufacturer's YouTube channel: Bronchial Thermoplasty Day in Pennsylvania

Here is how the procedure looks like, again from the manufacturer's channel:


 

International respiratory societies call for collaboration on asthma

Juan Carlos Ivancevich Friday, 06 May 2016 20:55

The Forum of International Respiratory Societies (FIRS) is calling for improved collaboration and funding to prevent and treat asthma.

In advance of World Asthma Day on May 3, the Forum of International Respiratory Societies issues a call to arms.

In World Asthma Day on May 3, FIRS says stakeholders must collaborate locally and globally to ensure adequate funding and resources are available to implement effective preventative and therapeutic strategies.

FIRS brings together the world’s leading international respiratory societies to work together to improve lung health globally. Members include the European Respiratory Society (ERS), International Union Against Tuberculosis and Lung Disease (The Union), the American Thoracic Society (ATS), and the American College of Chest Physicians (CHEST). The goal of the Forum is to unify and enhance efforts to improve lung health through the combined work of its 70,000+ members globally.

According to the Global Asthma Report 2014, up to 334 million people worldwide have asthma. Approximately 4.5% of young adults have been diagnosed with asthma and/or are taking asthma medication. An estimated 14% of children have had asthma symptoms in the past year.

In a statement issued by the ATS, FIRS says leaders in respiratory health must unite globally to invest in community-led solutions to improve quality of life, and reduce morbidity and mortality in asthma. It is calling on countries and organisations to invest and take necessary actions to encourage people-centred prevention, treatment and care to ensure that every person with asthma has access to high-value care.

World Asthma Day is an annual event organised by the Global Initiative for Asthma (GINA) to improve asthma awareness and care around the world. The theme for this year’s event is ‘You can control your asthma’ and it will be held on May 3.

The following new article has just been published in Asthma Research and Practice

Juan Carlos Ivancevich Thursday, 05 May 2016 13:04

Research   

A qualitative evaluation of the implementation of guidelines and a support tool for asthma management in primary care

Watkins K, Fisher C, Misaghian J, Schneider C, Clifford R

Asthma Research and Practice 2016, 2 :8 (4 May 2016)

Abstract | Full Text | PDF

Featured: Sickle cell disease: wheeze or asthma?

Juan Carlos Ivancevich Monday, 18 April 2016 20:10

Child maltreatment and pediatric asthma: a review of the literature

Juan Carlos Ivancevich Tuesday, 12 April 2016 12:37

Hannah M. C. Schreier, Edith Chen and Gregory E. Miller

Abstract

Background

Child maltreatment is a common problem with known adverse consequences, yet its contributions to the development and course of pediatric asthma are only poorly understood.

Main

This review first describes possible pathways connecting child maltreatment to pediatric asthma, including aspects of the physical home environment, health behaviors and disease management, and psychological consequences of child maltreatment. We subsequently review existing studies, which generally report an association between maltreatment experiences and asthma outcomes in childhood. However, this literature is in its early stages; there are only a handful studies, most of them rely on self-reports of both child maltreatment and asthma history, and none have investigated the physiological underpinnings of this association. Taken together, however, the studies are suggestive of child maltreatment playing a role in pediatric asthma incidence and expression that should be explored further.

Conclusion

Existing data are sparse and do not allow for specific conclusions. However, the data are suggestive of child maltreatment influencing asthma risk and morbidity long before the adult years. Future research should focus on understanding how child maltreatment contributes to asthma disease risk and progression in this highly vulnerable population.

Download PDF

CXC chemokine superfamily induced by Interferon-γ in asthma: a cross-sectional observational study

Juan Carlos Ivancevich Friday, 18 March 2016 12:49

 

 

 

 

Article alert

 

The following new article has just been published in Asthma Research and Practice

Research   

CXC chemokine superfamily induced by Interferon-γ in asthma: a cross-sectional observational study

Takaku Y, Soma T, Uchida Y, Kobayashi T, Nakagome K, Nagata M

Asthma Research and Practice 2016, 2 :6 (17 March 2016)

Abstract | Full Text | PDF

 

 

Interasma on Twitter

Interasma RT @Aller_MD: Top story: Kaléo on Twitter: "Some bullies use words, others use food. Togeth… https://t.co/eOHOsmB43X, see more https://t.…
9hreplyretweetfavorite
Interasma RT @Aller_MD: “Epinephrine Nasal Spray for #Anaphylaxis Shows Promise as Potential Alternative to Auto-Injector” https://t.co/qVsbyMfDuL ht…
9hreplyretweetfavorite
Interasma RT @Aller_MD: “Stress-related disorders were significantly associated with risk of subsequent autoimmune disease” https://t.co/9YWUsJgHWp h…
9hreplyretweetfavorite
Interasma RT @Aller_MD: “A Teledermatology Scale-Up Framework and Roadmap for Sustainable Scaling: Evidence-Based Development” https://t.co/nqPSJpsyg
9hreplyretweetfavorite
Interasma RT @Aller_MD: “Tobacco Product Use Among Youths With and Without Lifetime #Asthmahttps://t.co/wnj8AyUM7Z https://t.co/ydFozighl5
9hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma